医学辅助生殖后妊娠合并COVID-19的母婴结局:前瞻性COVID-19相关产科与新生儿结局研究结果
本研究为多中心前瞻性观察性队列研究,纳入1485例妊娠合并COVID-19女性,比较65例医学辅助生殖受孕与1420例自然受孕者的母婴结局。结果发现医学辅助生殖组产科和新生儿并发症风险更高,但医学辅助生殖并非不良结局的主要风险因素;母亲年龄、多胎妊娠、初产、孕前BMI>30和多胎妊娠独立贡献于不良妊娠结局风险增加。
要点
- 医学辅助生殖受孕组产科和新生儿并发症风险高于自然受孕组。
- 医学辅助生殖并非COVID-19孕妇不良母婴结局的主要风险因素。
- 母亲年龄、多胎妊娠、初产、孕前BMI>30和多胎妊娠独立增加不良妊娠结局风险。
核心结论
- 医学辅助生殖受孕的COVID-19孕妇不良产科和新生儿并发症发生率高于自然受孕者,但医学辅助生殖并非主要风险因素。
研究设计与样本
- 多中心、前瞻性、观察性队列研究(COVID-19相关产科与新生儿结局研究),纳入1485例妊娠合并COVID-19女性,其中医学辅助生殖受孕65例,自然受孕1420例。
主要发现
- COVID-19相关不良结局(如肺炎、入住重症监护室和死亡)在医学辅助生殖受孕与自然受孕女性间无差异。
- 医学辅助生殖受孕组产科和新生儿并发症风险更高。
- 医学辅助生殖并非妊娠相关高血压疾病、妊娠期糖尿病、宫颈机能不全、围产期出血、剖宫产、早产或入住新生儿重症监护室等不良母婴结局的主要风险因素。
- 母亲年龄、多胎妊娠、初产、孕前体重指数>30和多胎妊娠独立于医学辅助生殖,对COVID-19孕妇不良妊娠结局风险增加有不同贡献。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Severe acute respiratory syndrome coronavirus type 2 infections in pregnancy have been associated with maternal morbidity, admission to intensive care, and adverse perinatal outcomes such as preterm birth, stillbirth, and hypertensive disorders of pregnancy. It is unclear whether medically assisted reproduction additionally affects maternal and neonatal outcomes in women with COVID-19. OBJECTIVE: To evaluate the effect of medically assisted reproduction on maternal and neonatal outcomes in women with COVID-19 in pregnancy. STUDY DESIGN: A total of 1485 women with COVID-19 registered in the COVID-19 Related Obstetric and Neonatal Outcome Study (a multicentric, prospective, observational cohort study) were included. The maternal and neonatal outcomes in 65 pregnancies achieved with medically assisted reproduction and in 1420 spontaneously conceived pregnancies were compared. We used univariate und multivariate (multinomial) logistic regressions to estimate the (un)adjusted odds ratios and 95% confidence intervals for adverse outcomes. RESULTS: The incidence of COVID-19-associated adverse outcomes (eg, pneumonia, admission to intensive care, and death) was not different in women after conceptions with COVID-19 than in women after medically assisted reproduction pregnancies. Yet, the risk of obstetrical and neonatal complications was higher in pregnancies achieved through medically assisted reproduction. However, medically assisted reproduction was not the primary risk factor for adverse maternal and neonatal outcomes including pregnancy-related hypertensive disorders, gestational diabetes mellitus, cervical insufficiency, peripartum hemorrhage, cesarean delivery, preterm birth, or admission to neonatal intensive care. Maternal age, multiple pregnancies, nulliparity, body mass index >30 (before pregnancy) and multiple gestation contributed differently to the increased risks of adverse pregnancy outcomes in women with COVID-19 independent of medically assisted reproduction. CONCLUSION: Although women with COVID-19 who conceived through fertility treatment experienced a higher incidence of adverse obstetrical and neonatal complications than women with spontaneous conceptions, medically assisted reproduction was not the primary risk factor.
引用
- Ziert Y, Abou-Dakn M, Backes C, et al. Maternal and neonatal outcomes of pregnancies with COVID-19 after medically assisted reproduction: results from the prospective COVID-19-Related Obstetrical and Neonatal Outcome Study. Am J Obstet Gynecol. 2022. PMID: 35452651. doi:10.1016/j.ajog.2022.04.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。